Skip to content

Mobile Self Management and Support for Adolescents and Young Adults With Cancer

Mobile Self Management and Support for Adolescents and Young Adults With Cancer

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT03130751
Enrollment
20
Registered
2017-04-26
Start date
2017-05-23
Completion date
2017-08-10
Last updated
2017-10-11

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Sarcoma

Brief summary

This study is the user testing phase of a mobile application intervention which will be designed to promote positive coping skills, illness resilience, and social support, and to serve as a complement to patient-physician interactions in adolescents and young adults (AYA) with sarcoma. User testing will be conducted with a prototype of the app. Participants will be AYA ages 13-25 with sarcoma (N=16). Study participation involves the AYAs downloading and using the app for 30 days. During the 30 days, participants will interact with the app by inputting their current mood, receiving supportive feedback from the app, reading messages, and doing brief activities (such as relaxation activities, etc.). Participants will also participate in an online focus group focused around the user experience. Before and after the 30 days of user testing, participants will complete a few brief questionnaires about their behavior, how their symptoms affect their life, and how they receive support from others. These questions will take around 20 minutes to complete at each administration.

Interventions

BEHAVIORALPocket Coach for AYA with Cancer

The Pocket Coach for AYA with Cancer is a psychosocial intervention to be delivered through a mobile platform. Intervention content is based on Mindfulness Based Stress Reduction (MBSR) and the Resilience in Illness Model \[Dr. Joan E. Haase et al\] and includes modules on relaxation, mindfulness, cognitions, and self-compassion.

Sponsors

BodiMojo, Inc.
CollaboratorOTHER
University of California, Los Angeles
Lead SponsorOTHER

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
SUPPORTIVE_CARE
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
13 Years to 25 Years
Healthy volunteers
No

Inclusion criteria

1. Parent or self-reported (for participants 18+ years old) physician diagnosis of sarcoma 2. Daily use of a smartphone (iOS, Android, or Windows) or tablet 3. Current Facebook account that participant can use to participate in the focus group (or, be willing to create a Facebook account for this purpose). 4. Able and willing to give informed assent and comply with study requirements 5. For patients aged 13-17 years, have one caregiver willing and able to participate in the study 6. Able to read and speak English

Exclusion criteria

1. Patients that are not able to participate in the study due to their medical condition and/or treatment regimen, as determined by the patients' treating oncologist in conjunction with patients' family members 2. Inability to provide informed assent/permission/consent 3. Inability to read, speak, and understand English

Design outcomes

Primary

MeasureTime frameDescription
Feasibility30 days (from day 1 through day 30 of the 30-day intervention period)Determined by the number of days participants use the program. Program usage will be assessed on the back end of the technology platform, which tracks how often each participant opens the app and uses any of the features. Intervention will be deemed feasible if participants use the program on at least two thirds of the 30 days in the study period (i.e., 20 out of the 30 days).

Secondary

MeasureTime frameDescription
Change in level of mindfulnessPre-intervention to post-intervention (a span of 30 days)Assessed by the change in the total score on the Child and Adolescent Mindfulness Measure (CAMM) from pre-intervention to post-intervention. Calculated by subtracting the pre-intervention score from the post-intervention score. The CAMM is a 10-item measure whose total score can range from 0-40. Higher scores correspond to higher levels of mindfulness.

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 21, 2026